Skip Ribbon Commands
Skip to main content
Skip over global navigation links
U.S. Department of Health and Human Services

Industry Partners

2016 PHEMCE Stakeholders Workshop

Safe and effective drugs, vaccines, therapeutics and diagnostics help us tackle emerging infectious diseases to terrorist threats. Pharmaceutical companies have worked to develop the critical medical countermeasures we need to keep people healthy when disasters strike. In the past year, the federal government invested in products that fight Ebola, anthrax, pandemic influenza, antibiotic resistance, radiation injury and more.

The federal government partners with industry through the Public Health Medical Countermeasures Enterprise (PHEMCE) in multiple ways to assemble the needed medical countermeasures to respond to these types of threats, from straight-forward purchase of an existing product, to repurposing a promising product, and finally to develop a completely new medical countermeasure. The PHEMCE agencies, such as the Food and Drug Administration, the Biomedical Advanced Research and Development Agency and the National Institutes of Health all work together to achieve this purpose . We have achieved a lot through our public-private efforts, but there is still much more work that needs to be done to protect health in a disaster or emergency.

If your company is interested in meeting the challenges that emerging infectious diseases and terrorist threats pose to our nation’s health, join us for the Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Stakeholders Workshop on January 6-7, 2016.

The PHEMCE Stakeholders Workshop gives you an opportunity to learn about emerging trends and network with your colleagues in the pharmaceutical industry as well as many of the people who could buy or use your products, including first responders, emergency room physicians, hospital directors, and local, state and federal emergency planners.

During this event, you can learn how to develop or enhance effective partnerships with the government and understand some of the inner workings in ways that may help accelerate your own product development efforts. . For instance, we’ll talk about the status and future of the U.S. Food and Drug Administration’s medical countermeasure initiative to aid in the review process for these public health emergency products. Attendees also will learn about services the federal government can provide to encourage the development of specific countermeasures we need to be better prepared for potential health emergencies.

The workshop also will include sessions about clinical guidance for the use of medical countermeasures, how to deal with emerging infectious diseases, lessons learned during the response to the Ebola outbreak, and updates about current medical countermeasures policy and planning efforts.

Join professionals from the front lines of health to the production lines of the pharmaceutical companies and medical device manufacturers who develop medical countermeasures. Register today!

Logistical Details

  • This page last reviewed: December 29, 2015